Yoshiaki Nakamura

54PUBLICATIONS
380CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Cell and nuclear divisionHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Aug 20, 2026
Clinical significance of WES-defined ERBB2 amplification in resectable colorectal cancer.

|Aug 07, 2026
cfDNA-inferred putative clonal hematopoiesis during first-line platinum-to-PARP inhibitor maintenance in ovarian cancer.

|Jul 01, 2026
Cell-Free DNA Analysis With Clinicopathologic Factors for Early Detection and Refining Lymph Node Metastasis Risk in T1 Colorectal Cancer: Results From the COSMOS-CRC Study.

|Jun 08, 2026
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial.

|May 18, 2026
Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss across Advanced Solid Tumors.

|Apr 29, 2026
Population-Based Identification of Clonal Hematopoiesis Using Peripheral Blood Whole-Genome Sequencing in Japan.

Pageof 9

Frequent Collaborators

46 joint publications

Takayuki Yoshino

35 joint publications

Hideaki Bando

17 joint publications

Eiji Oki

13 joint publications

Yoshito Komatsu